Benzinga | Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals

0.0000 0 (%)

Data as of Nov 22, 2024

Prev. Close
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio
Shares Outstanding
Market Cap

Trade EMA stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
1/27/21	Scotiabank	Upgrades	Sector PerformSector Outperform
11/16/20	UBS	Maintains	Buy	68.0
7/22/20	Credit Suisse	Downgrades	OutperformNeutral	60.0

Arena Pharmaceuticals Files European Marketing Authorization Application for Lorcaserin for Weight Control Matthew KennedyFri, 02 Mar 2012 08:01:44 -0500
Affymax to Receive $5 Million Milestone Payment for Acceptance of European Marketing Authorization Application for Peginesatide Matthew KennedyMon, 27 Feb 2012 08:01:58 -0500
Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis Matthew KennedyThu, 23 Feb 2012 09:01:20 -0500
Recordati and Nymox Announce the Start of European Phase III Clinical Trial for NX-1207 Allie WickmanTue, 21 Feb 2012 09:30:51 -0500
CHMP Recommends Approval of BYETTA for Use With Basal Insulin Matthew KennedyFri, 17 Feb 2012 07:55:00 -0500
Catalyst Pharmaceutical Partners Granted Orphan Medicinal Product Designation in European Union for CPP-115 Matthew KennedyMon, 13 Feb 2012 09:03:27 -0500
Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN in PTCL at the European Medicines Agency Matthew KennedyMon, 30 Jan 2012 08:30:45 -0500
Trius Earns $5 Million Milestone Payment From Bayer for Successful Completion of First Phase 3 Trial of Tedizolid Allie WickmanMon, 23 Jan 2012 07:00:52 -0500
Trius Reports Positive Results From First Phase 3 Trial of Tedizolid in Acute Bacterial Skin and Skin Structure Infections Allie WickmanMon, 19 Dec 2011 07:01:28 -0500
UPDATE: FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™ Allie WickmanTue, 13 Dec 2011 06:55:56 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Emera hits 52-week high on pact AccesswireJan 07, 2015
Loss of accreditation potentially disastrous for Toronto Zoo: but not a surprise Benzinga StaffApr 18, 2012
Three Ways CIOs Can Build Business Trust with Application Performance Monitoring Benzinga StaffApr 17, 2012
Enterprise Management Associates and Blazent Industry Experts to Present a Free CMDB Webinar PRWebApr 17, 2012
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermittent Claudication Benzinga StaffApr 17, 2012
Ohio Health System and City Fire Department Team Up for April 19 Disaster Exercise PRWebApr 16, 2012
Affymax and Takeda Announce Centers for Medicare and Medicaid Services Has Assigned a Q-Code for OMONTYS® (Peginesatide) Injection Benzinga StaffApr 13, 2012
Enterprise Management Associates to Present Free Webinar on Unified Demand Management PRWebApr 11, 2012
Affymax Receives a $50 Million Milestone Payment for U.S. Approval of OMONTYS® (peginesatide) Injection Benzinga StaffApr 09, 2012
Enterprise Management Associates Announces Free IT Management Webinars for April PRWebApr 05, 2012
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

AltaGas: Significant Rerating Upside In 2023 Seeking AlphaOct 23, 2022
AltaGas: Significant Rerating Upside In 2023 Seeking AlphaOct 23, 2022
Sinovac's COVID-19 shot undergoes rolling review in Europe Seeking AlphaMay 04, 2021
Sinovac's COVID-19 shot undergoes rolling review in Europe Seeking AlphaMay 04, 2021
Ocugen extends gains as CEO hints on EUA submission for COVID-19 vaccine Seeking AlphaApr 23, 2021
Ocugen extends gains as CEO hints on EUA submission for COVID-19 vaccine Seeking AlphaApr 23, 2021
EMA expediting review of J&J vaccine amid blood clot cases Seeking AlphaApr 14, 2021
EMA expediting review of J&J vaccine amid blood clot cases Seeking AlphaApr 14, 2021
France to OK mRNA vaccines in place of second dose of AstraZeneca's COVID-19 shot Seeking AlphaApr 08, 2021
France to OK mRNA vaccines in place of second dose of AstraZeneca's COVID-19 shot Seeking AlphaApr 08, 2021
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q4 2021	EST	Actual	Surprise
EPS:	0.650	0.640	-0.0100
Rev:	1.83B	1.87B	38.00M

Q1 2022	EST	Actual	Surprise
EPS:	Expected 2022-05-11
Rev:	Expected 2022-05-11

Market Overview

Tickers

Articles

Keywords

:

Analyst Rating View All Ratings

Earnings View Earnings